Abbvie Inc
NYSE:ABBV 4:00:00 PM EDT
| Market Cap (Intraday) | 291.56B |
| Current PE | 59.83 |
| Forward PE | 14.78 |
| 2yr Forward PE | 13.55 |
| 10-Day MA | $165.98 |
| 50-Day MA | $173.90 |
| 200-Day MA | $153.00 |
Abbvie Inc Stock, NYSE:ABBV
1 North Waukegan Road, North Chicago, Illinois 60064-6400
United States of America
Phone: +1.847.932.7900
Number of Employees: 50000
Description
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.